# Jason Wrone

> Jason Wrone is a Series A investor at Open Prairie backing Sustainability and AgTech. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Open Prairie](https://shizune.co/investors/profile/open-prairie)
- Total investments: 4
- Last investment: Jan 2021
- Lead investor: 50%
- Last updated: Aug 2026

Jason Wrone is a Series A investor at Open Prairie focused on Sustainability and AgTech. Jason is Vice President of Investments at Open Prairie Ventures. Jason is responsible for management of investment opportunities, oversight of existing portfolio companies, and quarterly reporting to limited partners. Jason has extensive experience in venture investing, real estate development and construction, strategic planning, sales, andmarketing.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Sustainability | 2 | 50% |
| AgTech | 1 | 25% |
| Livestock | 1 | 25% |
| Agriculture | 1 | 25% |
| Biotechnology | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Series B | 1 | 25% |
| Series C | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| HerdDogg | HerdDogg is a global herd health and data science platform. It is a two-part system that helps ranchers track health and proximity data from their herd. The company's device gathers the data captured by the ear tags and reports it directly to the rancher via an app or web database. | $4M | Series A | Jan 14, 2021 |  |
| NewLeaf Symbiotics | NewLeaf Symbiotics develops and commercializes the bacteria found in Pink Pigmented Facultative Methylotrophs. NewLeaf Symbiotics has also filed its own related patents and is actively developing new technologies related to PPFMs. It is engaged in laboratory, greenhouse, and field product trials and expects to commercialize and license productsbeginning in 2014. | $30M | Series C | Jul 10, 2017 |  |
| NewLeaf Symbiotics | NewLeaf Symbiotics develops and commercializes the bacteria found in Pink Pigmented Facultative Methylotrophs. NewLeaf Symbiotics has also filed its own related patents and is actively developing new technologies related to PPFMs. It is engaged in laboratory, greenhouse, and field product trials and expects to commercialize and license productsbeginning in 2014. | $17M | Series B | Sep 15, 2014 |  |
| NewLeaf Symbiotics | NewLeaf Symbiotics develops and commercializes the bacteria found in Pink Pigmented Facultative Methylotrophs. NewLeaf Symbiotics has also filed its own related patents and is actively developing new technologies related to PPFMs. It is engaged in laboratory, greenhouse, and field product trials and expects to commercialize and license productsbeginning in 2014. | $7M | Series A | Jan 09, 2013 |  |

4 of 4 investments shown.

## Co-investors
- [Pangaea Ventures](https://shizune.co/investors/profile/pangaea-ventures) — VC Fund, 3 deals together
- [RockPort Capital](https://shizune.co/investors/profile/rockport-capital-partners) — VC Fund, 3 deals together
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund, 1 deal together
- [Leaps by Bayer](https://shizune.co/investors/profile/leaps-by-bayer) — VC Fund, 1 deal together
- [Lewis & Clark Ventures](https://shizune.co/investors/profile/lewis---clark-ventures) — VC Fund, 1 deal together
- [Monsanto Growth Ventures (MGV)](https://shizune.co/investors/profile/monsanto-growth-ventures) — VC Fund, 1 deal together

## About Open Prairie

VC Fund · Champaign, United States

Open Prairie is a private equity fund management company with extensive roots in agriculture and rural America. The Open Prairie team has continually focused on increasing financial access in underserved communities and has managed investment portfolios spanning from venture capital to agriculture.

5 contacts available at Open Prairie.

| Name | Title | Profile |
| --- | --- | --- |
| Dennis Beard | Partner & CFO | https://shizune.co/investors/profile/dennis-beard |
| Jason Wrone | Vice President | https://shizune.co/investors/profile/jason-wrone |
| Jim Schultz | Founder & Chairman | https://shizune.co/investors/profile/jim-schultz-2 |
| Pat Morand | President | https://shizune.co/investors/profile/pat-morand |
| Sam Hogg | Venture Partner | https://shizune.co/investors/profile/sam-hogg |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Jason Wrone invest in?

Jason Wrone invests primarily in Sustainability, AgTech and Livestock startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jason Wrone last invest?

The most recent investment recorded for Jason Wrone closed in Jan 2021. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co